Cardiff & Vale University Health Board
Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ
Dr Nia J Jones is a Senior Researcher at CEDAR. This secondment from Cardiff and Vale University Health Board focuses on combining academic activities, translational research, and evaluation, alongside her advanced clinical practice role. Her background as a Highly Specialist Podiatrist with Cardiff and Vale University Health Board specialised in the management of lower limb threatening complications associated with Diabetes and Chronic Kidney Disease. This multi-disciplinary role provided opportunities for her to undertake a Post Graduate Certificate Teaching in Higher Education and successfully complete an RCBC funded PhD Fellowship at Cardiff Metropolitan University. She is an Advance HE (HEA) Fellow and Honorary Lecturer for the MSc in Wound Healing and Tissue Repair at Cardiff University. Since 2012, she has been a member of the European Diabetic Foot Study Group and peer reviewed for the International Wound Journal and Diabetic Medicine Journal as part of her academic development. In 2018, she was awarded a prestigious Innovator in Diabetes (IDia) Fellowship by Diabetes UK. The program aims to develop early career diabetes researchers as leaders in their field. It offers opportunities to expand knowledge, gain new skills, and network with other leading researchers in the field. Her role within Cardiff and Vale University Health Board includes Research & Development Lead for Podiatry and Deputy Research and Development Lead for Therapy Services. She has a keen academic interest in epidemiology, health economics, innovation and values-based healthcare. Her experience extends further to involve project management of sponsored research funded by the Commercial Sector and she has a strong track record of engaging with the Medical Technology and Pharmaceutical Industry. Over the past 7 years, she has undertaken a number of high-profile Audits and Service Improvement Projects funded by Welsh Government and the Clinical Commissioning Group in England. Participated in 14 Clinical Trials and managed the governance, delivery and reporting of over 15 Product Evaluations.